JP2010509241A5 - - Google Patents

Download PDF

Info

Publication number
JP2010509241A5
JP2010509241A5 JP2009535502A JP2009535502A JP2010509241A5 JP 2010509241 A5 JP2010509241 A5 JP 2010509241A5 JP 2009535502 A JP2009535502 A JP 2009535502A JP 2009535502 A JP2009535502 A JP 2009535502A JP 2010509241 A5 JP2010509241 A5 JP 2010509241A5
Authority
JP
Japan
Prior art keywords
inhibition
peptide
nanoparticles
combinations
group
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2009535502A
Other languages
English (en)
Japanese (ja)
Other versions
JP2010509241A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2007/083772 external-priority patent/WO2008058125A2/en
Publication of JP2010509241A publication Critical patent/JP2010509241A/ja
Publication of JP2010509241A5 publication Critical patent/JP2010509241A5/ja
Withdrawn legal-status Critical Current

Links

JP2009535502A 2006-11-07 2007-11-06 膜貫通ペプチドからなる自己凝集性ナノ粒子および抗癌剤の特異的腫瘍内送達のためのその利用 Withdrawn JP2010509241A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US86466506P 2006-11-07 2006-11-07
PCT/US2007/083772 WO2008058125A2 (en) 2006-11-07 2007-11-06 Self-assembling nanoparticles composed of transmembrane peptides and their application for specific intra-tumor delivery of anti-cancer drugs

Publications (2)

Publication Number Publication Date
JP2010509241A JP2010509241A (ja) 2010-03-25
JP2010509241A5 true JP2010509241A5 (enExample) 2010-12-09

Family

ID=39365311

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2009535502A Withdrawn JP2010509241A (ja) 2006-11-07 2007-11-06 膜貫通ペプチドからなる自己凝集性ナノ粒子および抗癌剤の特異的腫瘍内送達のためのその利用

Country Status (9)

Country Link
US (1) US9326950B2 (enExample)
EP (1) EP2086521A2 (enExample)
JP (1) JP2010509241A (enExample)
CN (1) CN101610759A (enExample)
AU (1) AU2007316416A1 (enExample)
CA (1) CA2668638A1 (enExample)
NZ (1) NZ576769A (enExample)
WO (1) WO2008058125A2 (enExample)
ZA (1) ZA200903125B (enExample)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101610759A (zh) * 2006-11-07 2009-12-23 美国政府卫生与公共服务部 由跨膜肽组成的自组装纳米颗粒及其用于特异性肿瘤内递送抗癌药物的应用
WO2012162628A2 (en) 2011-05-25 2012-11-29 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Lipopeptide inhibitors of ras oncoproteins
US9180203B2 (en) 2012-10-23 2015-11-10 The Johns Hopkins University Self-assembling drug amphiphiles and methods for synthesis and use
ES2625024B1 (es) * 2015-12-18 2018-05-10 Consejo Superior De Investigaciones Cientificas Material que comprende tectómeros de oligoglicina y nanohilos
WO2017173398A1 (en) 2016-04-01 2017-10-05 Duke University Alpha-helical peptide nanofibers as a self-adjuvanting vaccine platform
WO2019018572A1 (en) * 2017-07-18 2019-01-24 Duke University COMPOSITIONS AND METHODS COMPRISING SELF-ASSEMBLY PEPTIDE-POLYMER NANOFIBERS FOR SUBLINGUAL IMMUNIZATION
WO2026018050A1 (en) 2024-07-14 2026-01-22 Zare Zardini Hadi Pistacia-derived bioactive peptides encapsulated in soy protein nanoparticles as an anticancer drug

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT892801E (pt) 1996-04-12 2002-06-28 Us Gov Health & Human Serv Compostos derivados de acridona uteis como agentes antineoplasicos e antiretrovirais
US7105488B1 (en) 1998-02-27 2006-09-12 The United States Of America As Represented By The Department Of Health And Human Services G protein-coupled receptor antagonists
CA2321962C (en) 1998-02-27 2014-07-15 The Government Of The United States Of America, Represented By The Secretary Of The Department Of Health And Human Services G protein-coupled receptor antagonists
US7517849B1 (en) * 1999-11-18 2009-04-14 The United States Of America As Represented By The Secretary Of Health And Human Services Inhibition of ABC transporters by transmembrane domain analogs
AU2001240054B2 (en) 2000-03-07 2005-08-11 The Government Of The United States Of America, As Represented By The Secretary, Department Of Health And Human Services 1,8-Naphthalimide Imidazo[4,5,1-de]acridones with Anti-Tumor Activity
CN1981873A (zh) * 2000-06-09 2007-06-20 莱古伦公司 制备微胶粒的方法和所述微胶粒的用途
WO2002062823A2 (en) * 2001-02-02 2002-08-15 Yale University Peptides for facilitating composite receptor expression and translocation of macromolecules
WO2006010083A2 (en) * 2004-07-08 2006-01-26 Molecular Therapeutics, Inc. Biodegradable nanoparticles
CN101610759A (zh) * 2006-11-07 2009-12-23 美国政府卫生与公共服务部 由跨膜肽组成的自组装纳米颗粒及其用于特异性肿瘤内递送抗癌药物的应用

Similar Documents

Publication Publication Date Title
Sedighi et al. Multifunctional self-assembled peptide hydrogels for biomedical applications
Wang et al. Recent advances in the fabrication, functionalization, and bioapplications of peptide hydrogels
AU2024202093A1 (en) Peptides and nanoparticles for intracellular delivery of mrna
Tikhomirov et al. Exosomes: from potential culprits to new therapeutic promise in the setting of cardiac fibrosis
Zhao et al. Recent advances in CXCL12/CXCR4 antagonists and nano-based drug delivery systems for cancer therapy
KR102714709B1 (ko) 조건부 활성 폴리펩티드
Liang et al. Enzyme-assisted peptide folding, assembly and anti-cancer properties
CN111132999A (zh) 支架蛋白
Du et al. Targeting macrophage polarization for reinstating homeostasis following tissue damage
Zhang et al. Instructive design of triblock peptide amphiphiles for structurally complex micelle fabrication
KR20140103914A (ko) 운반물 경피 전달을 포함하는 타켓 전달용 다공성 나노입자-지지 지질 이중층(프로토셀) 및 그 방법
JP2014500867A (ja) 皮膚浸透性および細胞侵入性(space)ペプチドとその使用法
AU2019210188B2 (en) Altering inflammatory states of immune cells in vivo by modulating cellular activation states
JP5721729B2 (ja) 活性産生送達分子
CN110121506A (zh) 条件活性多肽及产生它们的方法
JP6175055B2 (ja) ウイルス感染増強特性を有するペプチドおよびその使用
CN111787912A (zh) 用于核酸分子递送的纳米颗粒-水凝胶复合物
JP2006525796A5 (enExample)
Liang et al. Injectable DNA hydrogels with intrinsic antioxidant and anti-inflammatory functions for effectively healing bacteria-infected diabetic wounds
Yang et al. Emerging gene therapy based on nanocarriers: a promising therapeutic alternative for cardiovascular diseases and a novel strategy in valvular heart disease
Scognamiglio et al. Dancing with Nucleobases: Unveiling the Self-Assembly Properties of DNA and RNA Base-Containing Molecules for Gel Formation
Kwon et al. Enhancing the biological functionality of hydrogels using self-assembling peptides
Gándara et al. Delivery of therapeutic biopolymers employing silica-based nanosystems
JP2016535600A5 (enExample)
CN120037351A (zh) 一种新降解途径的蛋白质降解治疗疾病的组合物